DDB2 knockdown increased the in vitro sphere formation capability and in vivo tumorigenicity of 2008 ovarian cancer cells (Fig. 5e–h), indicating an expansion of CSCs in DDB2 downregulated 2008 cells, which was also shown in Supplementary Figure 1. The gene discussed is DDB2; the disease is ovarian cancer.